CDC Director Nomination Delayed Past Federal Deadline

The White House is facing scrutiny as the deadline passed on Wednesday, March 25, 2026, without a nomination for a new director of the Centers for Disease Control and Prevention (CDC). The delay extends a period of interim leadership at the agency, raising questions about long-term stability and public health preparedness. While the administration maintains its commitment to restoring confidence in the CDC, the lack of a permanent appointment continues to draw attention, particularly given recent leadership turnover and the ongoing need for a steady hand in navigating public health challenges.

According to White House spokesperson Kush Desai, National Institutes of Health (NIH) Director Jay Bhattacharya will continue to serve as acting CDC director until a permanent nominee is selected. Healio News first reported the administration’s decision to delay the nomination.

A Succession of Interim Leaders

Bhattacharya’s appointment followed that of Jim O’Neill, who served as acting director for over five months. O’Neill’s tenure came after Susan Monarez was removed from the position just weeks into her term as the only permanent director appointed during the previous administration. This series of short-term appointments underscores a period of instability at the CDC, a critical agency responsible for protecting public health and responding to emerging threats.

The Vacancies Reform Act limits the duration an executive branch position can be filled on an acting basis to 210 days. The clock began ticking when O’Neill was named acting director on August 29, 2025, putting pressure on the White House to identify a permanent replacement.

Restoring Confidence in CDC Decision-Making

Desai emphasized that “restoring competence and confidence in CDC decision-making remains a top priority for the White House.” He added that Bhattacharya’s leadership is a “great service to the country” and will ensure continuity while the administration searches for a permanent director. This statement alludes to criticisms leveled against the CDC during the COVID-19 pandemic, where concerns were raised about communication, data transparency, and the agency’s evolving guidance.

The White House’s focus on restoring confidence reflects a broader effort to address public trust in public health institutions, which has been eroded in recent years. A stable and experienced leader at the CDC is seen as crucial for rebuilding that trust and effectively responding to future health crises.

Potential Nominees and the Path Forward

Reports indicate that the administration is considering several candidates for the CDC director position, including former Kentucky Governor Ernie Fletcher, MD. Mississippi state health officer Daniel Edney, MD, FACP, FASAM; and Johns Hopkins cardiologist Joseph Marine, MD. The selection process likely involves careful vetting of candidates’ qualifications, experience, and perspectives on key public health issues.

Lawrence Gostin, JD, professor and founding director of the O’Neill Institute for National and Global Health Law at Georgetown University, noted that while there are no immediate legal ramifications for delaying the nomination, “there are certainly public health consequences.” He expressed concern that the absence of a permanent director leaves the agency vulnerable to the influence of the Department of Health and Human Services (HHS) Secretary.

The Role of the CDC Director

The CDC director plays a pivotal role in shaping national public health policy and responding to outbreaks of infectious diseases. The director is responsible for leading a vast organization with a broad mandate, including disease surveillance, prevention programs, and emergency preparedness. A strong and effective director is essential for protecting the health of the American public.

The CDC’s responsibilities extend beyond infectious diseases to encompass chronic diseases, environmental health, and injury prevention. The director must be able to navigate complex scientific, political, and ethical challenges to effectively address these diverse public health concerns. The CDC website provides a detailed overview of the director’s responsibilities and the agency’s mission.

Ongoing Public Health Concerns

The delay in naming a permanent CDC director comes at a time of ongoing public health challenges. In addition to the lingering effects of the COVID-19 pandemic, the United States is facing outbreaks of other infectious diseases, such as measles. The California Department of Public Health recently issued a health alert regarding six cases of measles in Sacramento and Placer County, representing the third outbreak of measles in the state this year.

the U.S. Food and Drug Administration (FDA) is investigating an outbreak of E. Coli O157:H7 illnesses linked to raw cheddar cheese, with two people hospitalized. eFoodAlert provides updates on food recalls and alerts, including the E. Coli outbreak.

What Comes Next: A Period of Uncertainty

The White House has indicated that it will nominate a permanent CDC director “in short order.” However, the timing of the nomination remains uncertain. The administration will likely weigh a variety of factors, including the candidates’ qualifications, political considerations, and the evolving public health landscape. Until a permanent director is appointed, Jay Bhattacharya will continue to lead the agency, providing a degree of continuity during a period of transition. The ongoing situation highlights the importance of strong leadership and a stable organizational structure at the CDC to effectively address the nation’s public health needs.

Lawrence Gostin, JD, can be reached at [email protected].